China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · IEX Real-Time Price · USD
1.680
0.00 (0.00%)
At close: Mar 27, 2024, 4:00 PM
1.800
+0.120 (7.14%)
Pre-market: Mar 28, 2024, 4:47 AM EDT

China SXT Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.
Year 2022202120202019201820172016
Net Income
-5.93-5.74-2.75-10.291.541.191.19
Depreciation & Amortization
0.320.320.350.330.180.130.1
Share-Based Compensation
0.552.3300000
Other Operating Activities
4.983.351.0910.89-1.480.6-0.99
Operating Cash Flow
-0.080.27-1.320.930.241.920.29
Operating Cash Flow Growth
---290.58%-87.54%555.25%-
Capital Expenditures
-0.07-0.06-0.09-0.41-0.6-1.03-0.18
Acquisitions
0.060.023.13-3.59000
Change in Investments
00-8.85-1.5000
Other Investing Activities
-----0.01-0.02-0.01
Investing Cash Flow
-0.01-0.05-5.81-5.5-0.61-1.05-0.19
Share Issuance / Repurchase
2.193.09006.4900
Debt Issued / Paid
0.75-1.4912.416.720.07-0.31-0.05
Other Financing Activities
----3.72.48--
Financing Cash Flow
2.941.612.413.029.04-0.31-0.05
Exchange Rate Effect
-1.050.390.78-0.47-0.040.04-0
Net Cash Flow
1.82.216.07-28.630.590.05
Free Cash Flow
-0.150.21-1.410.53-0.360.890.11
Free Cash Flow Growth
-----682.03%-
Free Cash Flow Margin
-450.44%60.69%-159.28%159.67%-169.51%67.61%15.57%
Free Cash Flow Per Share
-0.574.95-48.9842.67-34.9789.0511.39
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).